Clinical observation on the use of topical nitroglycerin in the management of severe shoulder-hand syndrome.

A. P. Manahan, K. A. Burkman, Mark A. Malesker, G. W. Benecke

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A simple widely endorsed treatment protocol for RSD does not exist in the literature. This lack of established management procedures reflects the multiple and often undetermined predisposing factors and variances in patient presentation. The most important factor in the successful management of RSD is early recognition and treatment. The goal of therapy is to relieve pain, limit swelling, prevent complications and restore function of the involved limb. Medical treatment becomes a more difficult challenge in the late stage. Treatment regimens for stage III RSD have been largely unsuccessful, and their benefits infrequently maintained. We observed increased level of function, as well as subjective improvement of pain and reduction of edema in our patient. Additional evaluation will help define the role of venous dilation as it relates to the efficacy and optimum utility of NTG in the adjunct management of stage III RSD. To further document the clinical efficacy of topical nitroglycerin as an adjunct in the management of stage III RSD, placebo controlled studies are indicated.

Original languageEnglish
Pages (from-to)87-89
Number of pages3
JournalThe Nebraska medical journal
Volume78
Issue number4
StatePublished - Apr 1993
Externally publishedYes

Fingerprint

Reflex Sympathetic Dystrophy
Nitroglycerin
Pain
Therapeutics
Clinical Protocols
Causality
Dilatation
Edema
Extremities
Placebos

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Clinical observation on the use of topical nitroglycerin in the management of severe shoulder-hand syndrome. / Manahan, A. P.; Burkman, K. A.; Malesker, Mark A.; Benecke, G. W.

In: The Nebraska medical journal, Vol. 78, No. 4, 04.1993, p. 87-89.

Research output: Contribution to journalArticle

@article{19a3666df4b5458095c180cf3b44f8cc,
title = "Clinical observation on the use of topical nitroglycerin in the management of severe shoulder-hand syndrome.",
abstract = "A simple widely endorsed treatment protocol for RSD does not exist in the literature. This lack of established management procedures reflects the multiple and often undetermined predisposing factors and variances in patient presentation. The most important factor in the successful management of RSD is early recognition and treatment. The goal of therapy is to relieve pain, limit swelling, prevent complications and restore function of the involved limb. Medical treatment becomes a more difficult challenge in the late stage. Treatment regimens for stage III RSD have been largely unsuccessful, and their benefits infrequently maintained. We observed increased level of function, as well as subjective improvement of pain and reduction of edema in our patient. Additional evaluation will help define the role of venous dilation as it relates to the efficacy and optimum utility of NTG in the adjunct management of stage III RSD. To further document the clinical efficacy of topical nitroglycerin as an adjunct in the management of stage III RSD, placebo controlled studies are indicated.",
author = "Manahan, {A. P.} and Burkman, {K. A.} and Malesker, {Mark A.} and Benecke, {G. W.}",
year = "1993",
month = "4",
language = "English",
volume = "78",
pages = "87--89",
journal = "The Nebraska medical journal",
issn = "0091-6730",
publisher = "Nebraska State Medical Association",
number = "4",

}

TY - JOUR

T1 - Clinical observation on the use of topical nitroglycerin in the management of severe shoulder-hand syndrome.

AU - Manahan, A. P.

AU - Burkman, K. A.

AU - Malesker, Mark A.

AU - Benecke, G. W.

PY - 1993/4

Y1 - 1993/4

N2 - A simple widely endorsed treatment protocol for RSD does not exist in the literature. This lack of established management procedures reflects the multiple and often undetermined predisposing factors and variances in patient presentation. The most important factor in the successful management of RSD is early recognition and treatment. The goal of therapy is to relieve pain, limit swelling, prevent complications and restore function of the involved limb. Medical treatment becomes a more difficult challenge in the late stage. Treatment regimens for stage III RSD have been largely unsuccessful, and their benefits infrequently maintained. We observed increased level of function, as well as subjective improvement of pain and reduction of edema in our patient. Additional evaluation will help define the role of venous dilation as it relates to the efficacy and optimum utility of NTG in the adjunct management of stage III RSD. To further document the clinical efficacy of topical nitroglycerin as an adjunct in the management of stage III RSD, placebo controlled studies are indicated.

AB - A simple widely endorsed treatment protocol for RSD does not exist in the literature. This lack of established management procedures reflects the multiple and often undetermined predisposing factors and variances in patient presentation. The most important factor in the successful management of RSD is early recognition and treatment. The goal of therapy is to relieve pain, limit swelling, prevent complications and restore function of the involved limb. Medical treatment becomes a more difficult challenge in the late stage. Treatment regimens for stage III RSD have been largely unsuccessful, and their benefits infrequently maintained. We observed increased level of function, as well as subjective improvement of pain and reduction of edema in our patient. Additional evaluation will help define the role of venous dilation as it relates to the efficacy and optimum utility of NTG in the adjunct management of stage III RSD. To further document the clinical efficacy of topical nitroglycerin as an adjunct in the management of stage III RSD, placebo controlled studies are indicated.

UR - http://www.scopus.com/inward/record.url?scp=0027585001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027585001&partnerID=8YFLogxK

M3 - Article

C2 - 7683774

AN - SCOPUS:0027585001

VL - 78

SP - 87

EP - 89

JO - The Nebraska medical journal

JF - The Nebraska medical journal

SN - 0091-6730

IS - 4

ER -